Cite

HARVARD Citation

    Cloyd, C. et al. (n.d.). 1014: ANAKINRA DOSING FOR MACROPHAGE ACTIVATION SYNDROME DURING CONTINUOUS RENAL REPLACEMENT THERAPY. Critical care medicine. p. 504. [Online]. 
  
Back to record